Radcliffe Capital Management, L.P. - BIOPLUS ACQUISITION CORP ownership

BIOPLUS ACQUISITION CORP's ticker is and the CUSIP is G11217117. A total of 57 filers reported holding BIOPLUS ACQUISITION CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Radcliffe Capital Management, L.P. ownership history of BIOPLUS ACQUISITION CORP
ValueSharesWeighting
Q3 2023$7,790,647
+1.8%
718,701
-0.0%
0.97%
+48.6%
Q2 2023$7,654,656
+2.4%
718,747
+0.4%
0.65%
+39.6%
Q1 2023$7,474,403
+31.2%
715,939
+28.9%
0.47%
+159.4%
Q4 2022$5,697,942
+41.5%
555,355
+38.4%
0.18%
+85.6%
Q3 2022$4,027,000
+0.2%
401,2790.0%0.10%
+5.4%
Q2 2022$4,019,000
+1.7%
401,279
+0.3%
0.09%
+2.2%
Q1 2022$3,953,000400,1000.09%
Other shareholders
BIOPLUS ACQUISITION CORP shareholders Q1 2022
NameSharesValueWeighting ↓
Quarry LP 455,000$4,845,7501.58%
Spartan Fund Management Inc. 270,578$3,414,7300.83%
First Trust Capital Management L.P. 1,106,378$11,782,9260.70%
Radcliffe Capital Management, L.P. 718,747$7,654,6560.65%
Westchester Capital Management, LLC 1,390,000$14,803,5010.46%
METEORA CAPITAL, LLC 235,223$2,505,1250.46%
BERKLEY W R CORP 597,631$6,364,7700.38%
MIZUHO SECURITIES USA LLC 1,014,334$10,731,6540.36%
Exos TFP Holdings LLC 60,000$639,0000.32%
AQR Arbitrage LLC 482,993$5,143,8750.22%
View complete list of BIOPLUS ACQUISITION CORP shareholders